Guanfacine Hydrochloride
NDC 53746-711, Guanfacine, tablet, from Amneal Pharmaceuticals of New York LLC.
- Product NDC
- 53746-711
- Status
- Listed
- Labeler
- Amneal Pharmaceuticals of New York LLC
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA075109
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/53746-711 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GUANFACINE HYDROCHLORIDE1 mg/1
Pharmacologic classes
Adrenergic alpha2-Agonists [MoA]; Central alpha-2 Adrenergic Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 53746-711-01 | 53746071101 | 100 TABLET in 1 BOTTLE (53746-711-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/73d50917-c807-4213-8efe-aea209845936NADAC price for package 53746071101
GET /v1/drugs/nadac/53746071101
Use it
Look up 53746-711 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/53746-711 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 53746-711. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.